Literature DB >> 31189341

Pediatric Antibiotic Pack Size Compliance With the Dosage Regimen: A Descriptive Study.

Iram Malik1, Muhammad Atif1, Fatima Riaz1, Saima Asghar1, Nafees Ahmad2.   

Abstract

BACKGROUND: The unavailability of appropriate pediatric drug pack size is a global issue. Antibiotics are the lifesaving and most frequently prescribed therapeutic agents given to pediatrics. The objective of this study was to assess the compliance of pediatric antibiotic pack size with the standard dosage regimen.
METHODS: A descriptive study design was employed. Data were collected from a community pharmacy in Bahawalpur, Pakistan, between August 1, 2017, and September 30, 2017. Five most commonly prescribed antibiotics were selected and calculations were made to check the appropriateness of packaging size by comparing the quantity of product in the available pack with the dosage regimen recommended by the British National Formulary for Children (BNFC).
RESULTS: Only 16 clarithromycin, 9 amoxicillin, 1 cefotaxime, and 1 metronidazole packaging sizes were sufficient to meet the dosage regimen for treatment. None of the available pack sizes for gentamicin matched the recommended duration of treatment. The study findings revealed that the available pack sizes either had leftover or a shortfall of antibiotic formulation. Highly inappropriate dosage forms (containing either excess and less quantity) of antibiotics were intravenous infusions and oral suspensions.
CONCLUSION: The study concluded that the packaging sizes of antibiotics failed to supply the recommended dosage regimen to pediatrics for common indications. This may contribute to development of antibiotic resistance among pediatric patients. Health policy makers should devise strict rules and regulations to ensure the availability of child-specific antibiotic pack sizes.

Entities:  

Keywords:  British National Formulary for Children; antibiotic pack sizes; antibiotic resistance; compliance; irrational antibiotic use; leftover medicine; pediatric dosage regimen; pediatric formulations

Year:  2019        PMID: 31189341     DOI: 10.1177/2168479019853770

Source DB:  PubMed          Journal:  Ther Innov Regul Sci        ISSN: 2168-4790            Impact factor:   1.778


  3 in total

1.  How medicines sales staff is responding to presumptive COVID-19 patients attending drug retail outlets: An exploratory qualitative study.

Authors:  Muhammad Atif; Muhammad Ahmad; Iram Malik; Irem Mushtaq; Nafees Ahmad; Zaheer-Ud-Din Babar
Journal:  Int J Health Plann Manage       Date:  2021-08-13

2.  Pharmacy Services beyond the Basics: A Qualitative Study to Explore Perspectives of Pharmacists towards Basic and Enhanced Pharmacy Services in Pakistan.

Authors:  Muhammad Atif; Wajiha Razzaq; Irem Mushtaq; Iram Malik; Madiha Razzaq; Shane Scahill; Zaheer-Ud-Din Babar
Journal:  Int J Environ Res Public Health       Date:  2020-03-31       Impact factor: 3.390

3.  COVID-19 and community pharmacy services in Pakistan: challenges, barriers and solution for progress.

Authors:  Muhammad Atif; Iram Malik
Journal:  J Pharm Policy Pract       Date:  2020-06-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.